Comparison of oxidative stress in pregnancies with and without first trimester iron supplement: A randomized double-blind controlled trial

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 15, 2014, Pages 1535-1538

  Korkmaz, Vakkas ^a   Ozkaya, Enis ^b   Seven, Banu Yuksel ^a   Duzguner, Soner ^a   Karsli, Mehmet Fatih ^c   Kucukozkan, Tuncay ^a  

^a Obstetrics and Gynecology   (Turkey)

^b Etlik Maternity and Women's Health Teaching Hospital   (Turkey)

^c Zekai Tahir Burak Women's Health Training and Research Hospital   (Turkey)

Author keywords

Iron supplementation; Isolated oligohydramnios; Oxidative stress

Indexed keywords

ALBUMIN; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; IRON; PLACEBO; ANTIANEMIC AGENT; TRACE ELEMENT;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; FEMALE; FIRST TRIMESTER PREGNANCY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; IRON THERAPY; OLIGOHYDRAMNIOS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; POSTMATURITY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; WEIGHT GAIN; ADVERSE EFFECTS; BLOOD; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG EFFECTS; PREGNANCY; YOUNG ADULT;

ADULT; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; GAMMA-GLUTAMYLTRANSFERASE; HEMATINICS; HUMANS; IRON; OXIDATIVE STRESS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; TRACE ELEMENTS; YOUNG ADULT;

EID: 84907062663     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.863869     Document Type: Article

References (17)

1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: anemia in pregnancy. Obstet Gynecol 2008;112:201-7.
2. Hamed EA, ElMelegy NT. Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Ital J Pediatr 2010;36:39.
3. Yokoyama H. Gamma glutamyl transpeptidase (gammaGTP) in the era of metabolic syndrome. Nihon Arukoru Yakubutsu Igakkai Zasshi 2007;42:110-24.
4. Campbell S, Lynch J, Esterman A, McDermott R. Pre-pregnancy predictors linked to miscarriage among Aboriginal and Torres Strait Islander women in North Queensland. Aust N Z J Public Health 2011;35:343-51.
5. Phelan JP, Smith CV, Broussard P, Small M. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation. J Reprod Med 1987;32:540-2.
6. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000;72:257-64.
7. World Health Organization (WHO). Iron deficiency anemia assessment prevention and control: a guide for program managers. Geneva: World Health Organization; 2001. Available from: http://www.who.int/nutrition/publications/en/ida-assessment-prevention-control.pdf [last accessed February 2012].
8. World Health Organization (WHO). Iron and folate supplementation. Standards for maternal and neonatal care. Integrated Management of Pregnancy and Childbirth (IMPAC). Geneva: World Health Organization; 2007. Available from: http://whqlibdoc. who.int/hq/2007/a91272.pdf [last accessed February 2012].
9. Senba M. Relationship between iron accumulation and portal fibrosis. Isr J Med Sci 1989;25:650-1.
10. Anetor JI, Ajose OA, Adeleke FN, et al. Depressed antioxidant status in pregnant women on iron supplements: pathologic and clinical correlates. Biol Trace Elem Res 2010;136:157-70.
11. Fenzl V, Flegar-Meštrić Z, Perkov S, et al. Trace elements and oxidative stress in hypertensive disorders of pregnancy. Arch Gynecol Obstet 2013;287:19-24.
12. Bodnar LM, Catov JM, Roberts JM. Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am J Obstet Gynecol 2007;196:324-5.
13. Falahi E, Akbari S, Ebrahimzade F, Gargari BP. Impact of prophylactic iron supplementation in healthy pregnant women on maternal iron status and birth outcome. Food Nutr Bull 2011;32: 213-17.
14. Haider BA, Olofin I, Wang M, et al.; Nutrition Impact Model Study Group (anaemia). Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 2013;346:f3443.
15. Amin SB, Orlando M, Wang H. Latent iron deficiency in utero is associated with abnormal auditory neural myelination in ≥35 weeks gestational age infants. J Pediatr 2013;163:1267-71.
16. Wiggins JE, Goyal M, Wharram BL, Wiggins RC. Antioxidant ceruloplasmin is expressed by glomerular parietal epithelial cells and secreted into urine in association with glomerular aging and high-calorie diet. J Am Soc Nephrol 2006;17:1382-7.
17. Rossi AC, Prefumo F. Perinatal outcomes of isolated oligohydramnios at term and post-term pregnancy: a systematic review of literature with meta-analysis. Eur J Obstet Gynecol Reprod Biol 2013;169:149-54.